Cargando…

SARS-CoV-2-specific T cells without antibodies

Detalles Bibliográficos
Autor principal:	Bozkus, Cansu Cimen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	In Brief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339101/ https://www.ncbi.nlm.nih.gov/pubmed/32636475 http://dx.doi.org/10.1038/s41577-020-0393-3

Ejemplares similares

Long-lasting SARS-CoV-2-specific T cell memories
por: Cimen Bozkus, Cansu
Publicado: (2020)

SARS-CoV-2 antibody seroconversion in care home
por: Shang, Joan, et al.
Publicado: (2020)

Antibody responses to SARS-CoV-2 short-lived
por: Vabret, Nicolas
Publicado: (2020)

Human antibodies can neutralize SARS-CoV-2
por: Catalan-Dibene, Jovani
Publicado: (2020)

A T-cell-based immunogenicity protocol for evaluating human antigen-specific responses
por: Cimen Bozkus, Cansu, et al.
Publicado: (2021)

Antibody response to SARS-CoV-2 — sustained after all?
por: Compeer, Ewoud B., et al.
Publicado: (2020)

Outliers Matter—Correlation between S1 IgG SARS-CoV-2 Antibodies and Neutralizing SARS-CoV-2 Antibodies
por: Hocher, Berthold, et al.
Publicado: (2022)

Multiple sclerosis treatment blunts SARS-CoV-2 antibody response
por: Lemprière, Sarah
Publicado: (2021)

SARS-CoV-2 variant evades antibodies whilst maintaining fitness
por: Flemming, Alexandra
Publicado: (2021)

Aptamer BC 007’s Affinity to Specific and Less-Specific Anti-SARS-CoV-2 Neutralizing Antibodies
por: Haberland, Annekathrin, et al.
Publicado: (2021)

Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2
por: Dong, Qunfeng, et al.
Publicado: (2020)

SARS-CoV-2 ‘super-permissive’ cells
por: Hofer, Ursula
Publicado: (2022)

SARS-CoV-2 tunnels to new cells
por: Hofer, Ursula
Publicado: (2022)

Harmonization of Determination of SARS-CoV-2 Antibodies: Is It Always Possible?
por: Dittadi, Ruggero
Publicado: (2022)

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants
por: Anichini, Gabriele, et al.
Publicado: (2021)

Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD
por: Ray, Katrina
Publicado: (2021)

B cell persistence and evolution to SARS-CoV-2
por: Alrubayyi, Aljawharah
Publicado: (2020)

SARS-CoV-2 on the neural battleground
por: Pavillet, Clara Eléonore, et al.
Publicado: (2020)

SARS-CoV-2 likes it cool
por: Soares-Schanoski, Alessandra
Publicado: (2020)

Inactivated vaccine for SARS-CoV-2
por: Risson, Emma
Publicado: (2020)

Clotting and SARS-CoV-2 entry
por: Hofer, Ursula
Publicado: (2022)

Histone mimicry by SARS-CoV-2
por: York, Ashley
Publicado: (2022)

SARS-CoV-2 in penile tissue
por: Thomas, Tim
Publicado: (2022)

Antibody evidence of SARS-CoV-2 infection in healthcare workers in the Bronx
por: Sydney, Elana R., et al.
Publicado: (2020)

In-Silico Analysis of Monoclonal Antibodies against SARS-CoV-2 Omicron
por: Hu, Ye-Fan, et al.
Publicado: (2022)

Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant
por: Gao, Yu, et al.
Publicado: (2022)

Shared CD8(+) T cell receptors for SARS-CoV-2
por: Levantovsky, Rachel, et al.
Publicado: (2020)

A map of SARS-CoV-2 and host cell interactions
por: Malle, Louise
Publicado: (2020)

SARS-CoV-2-reactive T cells in patients and healthy donors
por: Pia, Luisanna
Publicado: (2020)

Immune correlates of SARS-CoV-2 protection
por: Brown, Matthew
Publicado: (2020)

SARS-CoV-2: too infectious to handle?
por: Coveney, Clarissa, et al.
Publicado: (2020)

Getting to the (germinal) centre of SARS-CoV-2
por: Richter, Felix Clemens, et al.
Publicado: (2020)

SARS-CoV-2 detection goes mobile
por: Clyde, Dorothy
Publicado: (2020)

Mapping host restriction of SARS-CoV-2
por: Gea-Mallorquí, Ester
Publicado: (2020)

Searching for relatives of SARS-CoV-2 in bats
por: York, Ashley
Publicado: (2021)

Soluble ACE2 in SARS-CoV-2 infection
por: Allison, Susan
Publicado: (2021)

Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization
por: Wang, Pengfei, et al.
Publicado: (2021)

Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia
por: Dashdorj, Naranjargal J., et al.
Publicado: (2021)

Antibody Responses after SARS-CoV-2 Vaccination in Patients with Liver Diseases
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2022)

Antibody Responses One Year after Mild SARS-CoV-2 Infection
por: Choe, Pyoeng Gyun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_acev2797n91samclvufuvhao1g